1. Ibáñez-Sanz G, Milà N, de la Peña-Negro LC, Garcia M, Vidal C, Rodríguez-Alonso L, Binefa G, Rodríguez-Moranta F, Moreno V. Proton-pump inhibitors are associated with a high false-positivity rate in faecal immunochemical testing.. J Gastroenterol. 2020; :. doi: 10.1007/s00535-020-01738-z. PubMed PMID:33159805 .

  2. Agustí C, Font-Casaseca N, Belvis F, Julià M, Vives N, Montoliu A, Pericàs JM, Casabona J, Benach J. The role of socio-demographic determinants in the geo-spatial distribution of newly diagnosed HIV infections in small areas of Catalonia (Spain).. BMC Public Health. 2020;20 (1):1533. doi: 10.1186/s12889-020-09603-7. PubMed PMID:33036599 PubMed Central PMC7547437.

  3. Louro J, Román M, Posso M, Comerma L, Vidal C, Saladié F, Alcantara R, Sanchez M, Quintana MJ, Del Riego J, Ferrer J, Peñalva L, Bargalló X, Prieto M, Sala M, Castells X. Differences in breast cancer risk after benign breast disease by type of screening diagnosis.. Breast. 2020; :. doi: 10.1016/j.breast.2020.09.005. PubMed PMID:33023825 .

  4. Vives N, Garcia de Olalla P, González V, Barrabeig I, Clotet L, Danés M, Borrell N, Casabona J, Catalan HIV and STI Surveillance Group. Recent trends in sexually transmitted infections among adolescents, Catalonia, Spain, 2012-2017.. Int J STD AIDS. 2020;31 (11):1047-1054. doi: 10.1177/0956462420940911. PubMed PMID:32753002 .

  5. Travier N, Fu M, Romaguera A, Martín-Cantera C, Fernández E, Vidal C, Garcia M, LUCAPREV research group. 6-Year Risk of Developing Lung Cancer in Spain: Analysis by Autonomous Communities.. Arch Bronconeumol. 2020; :. doi: 10.1016/j.arbres.2020.03.022. PubMed PMID:32402549 .

  6. Gómez-Acebo I, Dierssen-Sotos T, Palazuelos C, Castaño-Vinyals G, Pérez-Gómez B, Amiano P, Fernández-Villa T, Ardanaz E, Suarez-Calleja C, Alguacil J, Molina-Barceló A, Jiménez-Moleón JJ, Molero JA, Roca-Barceló A, Chirlaque MD, Vázquez JPF, Molinuevo A, Aragonés N, Serra MS, Binefa G, Moreno V, Pollán M, Kogevinas M, Llorca J. Changes in individual and contextual socio-economic level influence on reproductive behavior in Spanish women in the MCC-Spain study.. BMC Womens Health. 2020;20 (1):72. doi: 10.1186/s12905-020-00936-4. PubMed PMID:32293415 PubMed Central PMC7160989.

  7. Pons-Rodríguez A, Martínez-Alonso M, Perestelo-Pérez L, Garcia M, Sala M, Rué M, en nombre del grupo InforMa, El grupo InforMa está formado por. [Informed choice in breast cancer screening: the role of education].. Gac Sanit. 2020; :. doi: 10.1016/j.gaceta.2020.01.002. PubMed PMID:32173050 .

  8. Agustí C, Muñoz R, González V, Villegas L, Fibla J, Meroño M, Capitán A, Fernàndez-López L, Platteau T, Casabona J. Outreach HIV testing using oral fluid and online consultation of the results: Pilot intervention in Catalonia.. Enferm Infecc Microbiol Clin. 2020; :. doi: 10.1016/j.eimc.2020.01.020. PubMed PMID:32151468 .

  9. González-Marrón A, Martín-Sánchez JC, Garcia-Alemany F, Martínez-Martín E, Matilla-Santander N, Cartanyà-Hueso À, Vidal C, García M, Martínez-Sánchez JM. Primary and Secondary Prevention Strategies to Reduce the Impact of Lung Cancer in Women: Where Are We Now and Where Are We Going?. Arch Bronconeumol. 2020;56 (5):340. doi: 10.1016/j.arbres.2020.01.022. PubMed PMID:32143912 .

  10. Ochoa-Arnedo C, Flix-Valle A, Casellas-Grau A, Casanovas-Aljaro N, Herrero O, Sumalla EC, de Frutos ML, Sirgo A, Rodríguez A, Campos G, Valverde Y, Travier N, Medina JC. An exploratory study in breast cancer of factors involved in the use and communication with health professionals of Internet information.. Support Care Cancer. 2020;28 (10):4989-4996. doi: 10.1007/s00520-020-05335-x. PubMed PMID:32034515 .

  11. González-Marrón A, Martín-Sánchez JC, Garcia-Alemany F, Martínez-Martín E, Matilla-Santander N, Cartanyà-Hueso À, Vidal C, García M, Martínez-Sánchez JM. Estimation of the Risk of Lung Cancer in Women Participating in a Population-Based Breast Cancer Screening Program.. Arch Bronconeumol. 2020;56 (5):277-281. doi: 10.1016/j.arbres.2019.04.014. PubMed PMID:31629546 .

  12. Muñoz R, Agustí C, González V, Villegas L, Fernàndez-López L, Platteau T, Casabona J. [HIV screening in leisure spaces in Barcelona and Sitges in men who have sex with men].. Gac Sanit. ;34 (2):208-210. doi: 10.1016/j.gaceta.2019.05.013. PubMed PMID:31472946 .

  13. Stuardo Ávila V, Fuentes Alburquenque M, Muñoz R, Bustamante Lobos L, Faba A, Belmar Prieto J, Casabona J. Prevalence and Risk Factors for HIV Infection in a Population of Homosexual, Bisexual, and Other Men Who Have Sex with Men in the Metropolitan Region of Chile: A Re-emerging Health Problem.. AIDS Behav. 2020;24 (3):827-838. doi: 10.1007/s10461-019-02486-9. PubMed PMID:30953301 .

  14. Martín-Sánchez JC, González-Marrón A, Lidón-Moyano C, Matilla-Santander N, Fu M, Vidal C, Garcia M, Martinez-Sanchez JM. Smoking pattern and risk of lung cancer among women participating in cancer screening programmes.. J Public Health (Oxf). 2020;42 (1):90-97. doi: 10.1093/pubmed/fdy221. PubMed PMID:30608591 .

Search PubMed
  1. Natal C, Fernandez-Somoano A, Torá-Rocamora I, Vidal C, Castells X, Tardón A, Benign Lesion Study Group, Benign Lesion Study Group. Dissemination of health technologies: Trends in the use of diagnostic test in breast cancer screening.. J Healthc Qual Res. ;34 (4):177-184. doi: 10.1016/j.jhqr.2019.02.007. PubMed PMID:31713528 .

  2. Ibáñez-Sanz G, Garcia M, Milà N, Hubbard RA, Vidal C, Binefa G, Benito L, Moreno V, Adverse Effects on Colorectal Cancer Screening in Catalonia (EACC) Study Working Group. False-Positive Results in a Population-Based Colorectal Screening Program: Cumulative Risk from 2000 to 2017 with Biennial Screening.. Cancer Epidemiol Biomarkers Prev. 2019;28 (11):1909-1916. doi: 10.1158/1055-9965.EPI-18-1368. PubMed PMID:31488415 .

  3. Toribio MJ, Lope V, Castelló A, Salas D, Vidal C, Ascunce N, Santamariña C, Moreo P, Pedraz-Pingarrón C, Sánchez-Contador C, Aragonés N, Pérez-Gómez B, Pollán M. Prevalence of healthy lifestyles against cancer in Spanish women.. Sci Rep. 2019;9 (1):10638. doi: 10.1038/s41598-019-47180-x. PubMed PMID:31337864 PubMed Central PMC6650391.

  4. Travier N, Vidal C, Garcia M, Benito L, Medina P, Moreno V. Communication Channels Used by Women to Contact a Population-Based Breast Cancer Screening Program in Catalonia, Spain.. J Med Syst. 2019;43 (8):244. doi: 10.1007/s10916-019-1382-6. PubMed PMID:31236712 .

  5. Román M, Sala M, Baré M, Posso M, Vidal C, Louro J, Sánchez M, Peñalva L, Castells X, BELE study group. Changes in mammographic density over time and the risk of breast cancer: An observational cohort study.. Breast. 2019;46 :108-115. doi: 10.1016/j.breast.2019.04.007. PubMed PMID:31132476 .

  6. Pérez-Lacasta MJ, Martínez-Alonso M, Garcia M, Sala M, Perestelo-Pérez L, Vidal C, Codern-Bové N, Feijoo-Cid M, Toledo-Chávarri A, Cardona À, Pons A, Carles-Lavila M, Rue M, with the InforMa Group. Effect of information about the benefits and harms of mammography on women's decision making: The InforMa randomised controlled trial.. PLoS One. 2019;14 (3):e0214057. doi: 10.1371/journal.pone.0214057. PubMed PMID:30913217 PubMed Central PMC6435150.

  7. Benito L, Travier N, Binefa G, Vidal C, Espinosa J, Milà N, Garcia M. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.. Cancer Prev Res (Phila). 2019;12 (5):327-334. doi: 10.1158/1940-6207.CAPR-18-0091. PubMed PMID:30890542 .

  8. Buckland G, Travier N, Arribas L, Del Barco S, Pernas S, Zamora E, Bellet M, Cirauqui B, Margelí M, Muñoz M, Tusquets I, Arcusa A, Javierre C, Moreno F, Valverde Y, Jansen E, Chajès V, Castro C, Agudo A. Changes in dietary intake, plasma carotenoids and erythrocyte membrane fatty acids in breast cancer survivors after a lifestyle intervention: results from a single-arm trial.. J Hum Nutr Diet. 2019;32 (4):468-479. doi: 10.1111/jhn.12621. PubMed PMID:30663156 .

  9. Posso M, Louro J, Sánchez M, Román M, Vidal C, Sala M, Baré M, Castells X, BELE study group. Mammographic breast density: How it affects performance indicators in screening programmes?. Eur J Radiol. 2019;110 :81-87. doi: 10.1016/j.ejrad.2018.11.012. PubMed PMID:30599878 .

  10. Stoffel S, Benito L, Milà N, Travier N, Binefa G, Vidal C, Espinosa J, Moreno V, Garcia M. Testing behavioral interventions to optimize participation in a population-based colorectal cancer screening program in Catalonia, Spain.. Prev Med. 2019;119 :58-62. doi: 10.1016/j.ypmed.2018.12.013. PubMed PMID:30594532 .

Search PubMed
  1. González-Marrón A, Martín-Sánchez JC, Matilla-Santander N, Cartanyà-Hueso À, Lidón-Moyano C, Vidal C, García M, Martínez-Sánchez JM. Estimation of the adult population at high risk of developing lung cancer in the European Union.. Cancer Epidemiol. 2018;57 :140-147. doi: 10.1016/j.canep.2018.10.007. PubMed PMID:30497060 .

  2. Del Pozo MDP, Castelló A, Vidal C, Salas-Trejo D, Sánchez-Contador C, Pedraz-Pingarrón C, Moreo P, Santamariña C, Ederra M, Llobet R, Vioque J, Pérez-Gómez B, Pollán M, Lope V. Overeating, caloric restriction and mammographic density in Spanish women. DDM-Spain study.. Maturitas. 2018;117 :57-63. doi: 10.1016/j.maturitas.2018.09.006. PubMed PMID:30314562 .

  3. Guillamó E, Cobo-Calvo Á, Oviedo GR, Travier N, Álamo J, Niño-Mendez OA, Martínez-Yelamos A, Martínez-Yelamos S, Javierre C. Feasibility and Effects of Structured Physical Exercise Interventions in Adults with Relapsing-Remitting Multiple Sclerosis: A Pilot Study.. J Sports Sci Med. 2018;17 (3):426-436. . PubMed PMID:30116116 PubMed Central PMC6090399.

  4. Benito L, de la Cueva Ariza L, Delgado-Hito P, Martinez Momblan MA, Romero García M, García M. Identifying Coordination and Continuity of Care Indicators for Population-Based Cancer Screening Programs: A Delphi Study.. Nurs Res. ;67 (5):411-418. doi: 10.1097/NNR.0000000000000300. PubMed PMID:30052593 .

  5. Travier N, Buckland G, Vendrell JJ, Fernandez-Veledo S, Peiró I, Del Barco S, Pernas S, Zamora E, Bellet M, Margeli M, Cirauqui B, Muñoz M, Tusquets I, Arcusa A, Javierre C, Moreno F, Rodriguez A, Agudo A. Changes in metabolic risk, insulin resistance, leptin and adiponectin following a lifestyle intervention in overweight and obese breast cancer survivors.. Eur J Cancer Care (Engl). 2018;27 (4):e12861. doi: 10.1111/ecc.12861. PubMed PMID:29869823 .

  6. Fu M, Travier N, Martín-Sánchez JC, Martínez-Sánchez JM, Vidal C, Garcia M, LUCAPREV research group. Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria.. PLoS One. 2018;13 (4):e0195441. doi: 10.1371/journal.pone.0195441. PubMed PMID:29621354 PubMed Central PMC5886563.

  7. Lauby-Secretan B, Vilahur N, Bianchini F, Guha N, Straif K, International Agency for Research on Cancer Handbook Working Group. The IARC Perspective on Colorectal Cancer Screening.. N Engl J Med. 2018;378 (18):1734-1740. doi: 10.1056/NEJMsr1714643. PubMed PMID:29580179 PubMed Central PMC6709879.

  8. Guillamó E, Travier N, Oviedo GR, Fonseca-Nunes A, Alamo JM, Cos F, Roca A, Niño O, Agudo A, Javierre C. A Physical Test to Estimate Suitable Workloads for an Exercise Program in Breast Cancer Survivors.. J Strength Cond Res. 2018; :. doi: 10.1519/JSC.0000000000002337. PubMed PMID:29579014 .

  9. Román M, Caicoya M, Espinàs J, Sala M, Torá-Rocamora I, Quinta MJ, Vernet M, Saladié F, Romero A, Sánchez M, Baré M, Vidal C, Servitja S, Natal C, Corominas J, Ferrer J, Rodríguez-Arana A, Castells X, BELE Project study group. Clinical and histologic characteristics of breast cancers in women with previous pathologic diagnosis of benign breast disease in Spain.. Breast J. 2018;24 (4):509-518. doi: 10.1111/tbj.13003. PubMed PMID:29517151 .

  10. Dierssen-Sotos T, Gómez-Acebo I, Palazuelos C, Fernández-Navarro P, Altzibar JM, González-Donquiles C, Ardanaz E, Bustamante M, Alonso-Molero J, Vidal C, Bayo-Calero J, Tardón A, Salas D, Marcos-Gragera R, Moreno V, Rodriguez-Cundin P, Castaño-Vinyals G, Ederra M, Vilorio-Marqués L, Amiano P, Pérez-Gómez B, Aragonés N, Kogevinas M, Pollán M, Llorca J. Validating a breast cancer score in Spanish women. The MCC-Spain study.. Sci Rep. 2018;8 (1):3036. doi: 10.1038/s41598-018-20832-0. PubMed PMID:29445177 PubMed Central PMC5813036.

  11. Benito L, Farre A, Binefa G, Vidal C, Cardona A, Pla M, García M. Factors related to longitudinal adherence in colorectal cancer screening: qualitative research findings.. Cancer Causes Control. 2018;29 (1):103-114. doi: 10.1007/s10552-017-0982-z. PubMed PMID:29170881 .

  12. Lope V, García-Pérez J, Pérez-Gómez B, Pedraza-Flechas AM, Alguacil J, González-Galarzo MC, Alba MA, van der Haar R, Cortés-Barragán RA, Pedraz-Pingarrón C, Moreo P, Santamariña C, Ederra M, Vidal C, Salas-Trejo D, Sánchez-Contador C, Llobet R, Pollán M. Occupational exposures and mammographic density in Spanish women.. Occup Environ Med. 2018;75 (2):124-131. doi: 10.1136/oemed-2017-104580. PubMed PMID:29074552 .

  13. Benito L, Espinosa J, Binefa G, Vidal C, Lluch MT, Puig M, Fernandez M, Padrol I, García M. Population-based Cancer Screening: Measurement of Coordination and Continuity of Care.. Cancer Nurs. ;41 (4):E1-E11. doi: 10.1097/NCC.0000000000000514. PubMed PMID:28622194 .

Search PubMed
  1. Lope V, García-Pérez J, Pérez-Gómez B, Pedraza-Flechas AM, Alguacil J, González-Galarzo MC, Alba MA, van der Haar R, Cortés-Barragán RA, Pedraz-Pingarrón C, Moreo P, Santamariña C, Ederra M, Vidal C, Salas-Trejo D, Sánchez-Contador C, Llobet R, Pollán M. Occupational exposures and mammographic density in Spanish women.. Occup Environ Med. 2018;75 (2):124-131. doi: 10.1136/oemed-2017-104580. PubMed PMID:29074552 .

  2. Martínez-Alonso M, Carles-Lavila M, Pérez-Lacasta MJ, Pons-Rodríguez A, Garcia M, Rué M, InforMa Group. Assessment of the effects of decision aids about breast cancer screening: a systematic review and meta-analysis.. BMJ Open. 2017;7 (10):e016894. doi: 10.1136/bmjopen-2017-016894. PubMed PMID:28988175 PubMed Central PMC5640065.

  3. Carles M, Martínez-Alonso M, Pons A, Pérez-Lacasta MJ, Perestelo-Pérez L, Sala M, Vidal C, Garcia M, Toledo-Chávarri A, Codern N, Feijoo-Cid M, Romero A, Pla R, Soler-González J, Castells X, Rué M, InforMa Group. The effect of information about the benefits and harms of mammography on women's decision-making: study protocol for a randomized controlled trial.. Trials. 2017;18 (1):426. doi: 10.1186/s13063-017-2161-7. PubMed PMID:28899412 PubMed Central PMC5596499.

  4. Oviedo GR, Travier N, Guerra-Balic M. Sedentary and Physical Activity Patterns in Adults with Intellectual Disability.. Int J Environ Res Public Health. 2017;14 (9):. doi: 10.3390/ijerph14091027. PubMed PMID:28880236 PubMed Central PMC5615564.

  5. García-Pérez J, Pollán M, Pérez-Gómez B, González-Sánchez M, Cortés Barragán RA, Maqueda Blasco J, González-Galarzo MC, Alba MÁ, van der Haar R, Casas S, Vicente C, Medina P, Ederra M, Santamariña C, Moreno MP, Casanova F, Pedraz-Pingarrón C, Moreo P, Ascunce N, García M, Salas-Trejo D, Sánchez-Contador C, Llobet R, Lope V. Occupation and mammographic density: A population-based study (DDM-Occup).. Environ Res. 2017;159 :355-361. doi: 10.1016/j.envres.2017.08.028. PubMed PMID:28843166 .

  6. Posso M, Corominas JM, Serrano L, Román M, Torá-Rocamora I, Domingo L, Romero A, Quintana MJ, Vernet-Tomas M, Baré M, Vidal C, Sánchez M, Saladié F, Natal C, Ferrer J, Servitja S, Sala M, Castells X, BELE Study Group. Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case-control study.. Cancer Med. 2017;6 (6):1482-1489. doi: 10.1002/cam4.1080. PubMed PMID:28470951 PubMed Central PMC5463091.

  7. Pedraza-Flechas AM, Lope V, Vidal C, Sánchez-Contador C, Santamariña C, Pedraz-Pingarrón C, Moreo P, Ascunce N, Miranda-García J, Llobet R, Aragonés N, Salas-Trejo D, Pollán M, Pérez-Gómez B, DDM/Var-DDM-Spain. Thyroid disorders and mammographic density in Spanish women: Var-DDM study.. Breast. 2017;34 :12-17. doi: 10.1016/j.breast.2017.04.011. PubMed PMID:28456099 .

  8. Román M, Quintana MJ, Ferrer J, Sala M, Castells X. Cumulative risk of breast cancer screening outcomes according to the presence of previous benign breast disease and family history of breast cancer: supporting personalised screening.. Br J Cancer. 2017;116 (11):1480-1485. doi: 10.1038/bjc.2017.107. PubMed PMID:28427083 PubMed Central PMC5520087.

  9. Romaguera D, Gracia-Lavedan E, Molinuevo A, de Batlle J, Mendez M, Moreno V, Vidal C, Castelló A, Pérez-Gómez B, Martín V, Molina AJ, Dávila-Batista V, Dierssen-Sotos T, Gómez-Acebo I, Llorca J, Guevara M, Castilla J, Urtiaga C, Llorens-Ivorra C, Fernández-Tardón G, Tardón A, Lorca JA, Marcos-Gragera R, Huerta JM, Olmedo-Requena R, Jimenez-Moleon JJ, Altzibar J, de Sanjosé S, Pollán M, Aragonés N, Castaño-Vinyals G, Kogevinas M, Amiano P. Adherence to nutrition-based cancer prevention guidelines and breast, prostate and colorectal cancer risk in the MCC-Spain case-control study.. Int J Cancer. 2017;141 (1):83-93. doi: 10.1002/ijc.30722. PubMed PMID:28380695 .

  10. Pedraza-Flechas AM, Lope V, Moreo P, Ascunce N, Miranda-García J, Vidal C, Sánchez-Contador C, Santamariña C, Pedraz-Pingarrón C, Llobet R, Aragonés N, Salas-Trejo D, Pollán M, Pérez-Gómez B, DDM/Var-DDM-Spain. Sleep patterns, sleep disorders and mammographic density in spanish women: The DDM-Spain/Var-DDM study.. Maturitas. 2017;99 :105-108. doi: 10.1016/j.maturitas.2017.02.015. PubMed PMID:28364862 .

  11. Pedraza-Flechas AM, Lope V, Sánchez-Contador C, Santamariña C, Pedraz-Pingarrón C, Moreo P, Ederra M, Miranda-García J, Vidal C, Llobet R, Aragonés N, Salas-Trejo D, Pollán M, Pérez-Gómez B, DDM-Spain/Var-DDM. High Mammographic Density in Long-Term Night-Shift Workers: DDM-Spain/Var-DDM.. Cancer Epidemiol Biomarkers Prev. 2017;26 (6):905-913. doi: 10.1158/1055-9965.EPI-16-0507. PubMed PMID:28336582 .

  12. Buckland G, Pastor A, Lujan-Barroso L, Gonzalez CA, Travier N, Amiano P, Huerta JM, Agudo A, Navarro C, Chirlaque MD, Sánchez MJ, Rodríguez-Barranco M, Barricarte A, Ardanaz E, Dorronsoro M, Molinuevo A, Quirós JR, de la Torre R. Determination of oleanolic acid in human plasma and its association with olive oil intake in healthy Spanish adults within the EPIC Spain cohort study.. Mol Nutr Food Res. 2017;61 (8):. doi: 10.1002/mnfr.201600927. PubMed PMID:28319346 .

  13. Sawada N, Wark PA, Merritt MA, Tsugane S, Ward HA, Rinaldi S, Weiderpass E, Dartois L, His M, Boutron-Ruault MC, Turzanski-Fortner R, Kaaks R, Overvad K, Redondo ML, Travier N, Molina-Portillo E, Dorronsoro M, Cirera L, Ardanaz E, Perez-Cornago A, Trichopoulou A, Lagiou P, Valanou E, Masala G, Pala V, Hm Peeters P, T van der Schouw Y, Melander O, Manjer J, da Silva M, Skeie G, Tjønneland A, Olsen A, J Gunter M, Riboli E, J Cross A. The association between adult attained height and sitting height with mortality in the European Prospective Investigation into Cancer and Nutrition (EPIC).. PLoS One. 2017;12 (3):e0173117. doi: 10.1371/journal.pone.0173117. PubMed PMID:28257491 PubMed Central PMC5336260.

  14. Ibáñez-Sanz G, Díez-Villanueva A, Alonso MH, Rodríguez-Moranta F, Pérez-Gómez B, Bustamante M, Martin V, Llorca J, Amiano P, Ardanaz E, Tardón A, Jiménez-Moleón JJ, Peiró R, Alguacil J, Navarro C, Guinó E, Binefa G, Fernández-Navarro P, Espinosa A, Dávila-Batista V, Molina AJ, Palazuelos C, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, Moreno V. Risk Model for Colorectal Cancer in Spanish Population Using Environmental and Genetic Factors: Results from the MCC-Spain study.. Sci Rep. 2017;7 :43263. doi: 10.1038/srep43263. PubMed PMID:28233817 PubMed Central PMC5324108.

  15. Toledo-Chávarri A, Rué M, Codern-Bové N, Carles-Lavila M, Perestelo-Pérez L, Pérez-Lacasta MJ, Feijoo-Cid M, InforMa Study Group. A qualitative study on a decision aid for breast cancer screening: Views from women and health professionals.. Eur J Cancer Care (Engl). 2017;26 (3):. doi: 10.1111/ecc.12660. PubMed PMID:28145105 .

  16. Ibañez-Sanz G, Garcia M, Milà N, Rodríguez-Moranta F, Binefa G, Gómez-Matas J, Benito L, Padrol I, Barenys M, Moreno V. False-negative rate cannot be reduced by lowering the haemoglobin concentration cut-off in colorectal cancer screening using faecal immunochemical test.. Eur J Cancer Prev. 2017;26 (5):365-367. doi: 10.1097/CEJ.0000000000000281. PubMed PMID:27433880 .

  17. Benito L, Lluch MT, Falcó AM, García M, Puig M. Identifying Nursing Interventions in a Cancer Screening Program Using Nursing Interventions Classification Taxonomy.. Int J Nurs Knowl. 2017;28 (2):70-75. doi: 10.1111/2047-3095.12115. PubMed PMID:26411994 .

Search PubMed
  1. Benito L, García M, Binefa G, Mila N, Vidal C, Lluch MT, Puig M, Primary Care-Screening Working Group. Cross-sectional survey on awareness of colorectal cancer and a screening programme for primary health care professionals in Catalonia, Spain.. Eur J Cancer Care (Engl). 2016;25 (6):992-1004. doi: 10.1111/ecc.12450. PubMed PMID:26880138 .

  2. Cubiella J, Carballo F, Portillo I, Cruzado Quevedo J, Salas D, Binefa G, Milà N, Hernández C, Andreu M, Terán Á, Arana-Arri E, Ono A, Valverde MJ, Bujanda L, Hernández V, Morillas JD, Jover R, Castells A. Incidence of advanced neoplasia during surveillance in high- and intermediate-risk groups of the European colorectal cancer screening guidelines.. Endoscopy. 2016;48 (11):995-1002. doi: 10.1055/s-0042-112571. PubMed PMID:27485482 .

  3. Ibáñez-Sanz G, Garcia M, Rodríguez-Moranta F, Binefa G, Gómez-Matas J, Domènech X, Vidal C, Soriano A, Moreno V, ‘Adverse Effects on Colorectal Cancer Screening in Catalonia (EACC) Study’ Working Group. Prescription drugs associated with false-positive results when using faecal immunochemical tests for colorectal cancer screening.. Dig Liver Dis. 2016;48 (10):1249-54. doi: 10.1016/j.dld.2016.06.011. PubMed PMID:27378703 .

  4. Binefa G, García M, Peiró R, Molina-Barceló A, Ibáñez R, en nombre de los participantes del encuentro «¿Cómo reducir las desigualdades sociales en los programas de cribado de cáncer?». [How to assess and reduce social inequalities in cancer screening programmes].. Gac Sanit. ;30 (3):232-4. doi: 10.1016/j.gaceta.2016.01.008. PubMed PMID:26920750 .

  5. Castells X, Torá-Rocamora I, Posso M, Román M, Vernet-Tomas M, Rodríguez-Arana A, Domingo L, Vidal C, Baré M, Ferrer J, Quintana MJ, Sánchez M, Natal C, Espinàs JA, Saladié F, Sala M, BELE Study Group. Risk of Breast Cancer in Women with False-Positive Results according to Mammographic Features.. Radiology. 2016;280 (2):379-86. doi: 10.1148/radiol.2016151174. PubMed PMID:26878225 .

  6. Binefa G, Garcia M, Milà N, Fernández E, Rodríguez-Moranta F, Gonzalo N, Benito L, Clopés A, Guardiola J, Moreno V. Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000-2012).. Sci Rep. 2016;6 :19532. doi: 10.1038/srep19532. PubMed PMID:26787510 PubMed Central PMC4726304.

  7. Isidoro B, Lope V, Whelan D, Pedraz C, Sánchez-Contador C, Santamariña C, Moreo P, Vidal C, Salas-Trejo D, Ederra M, Aragonés N, Pérez-Gómez B, Pollán M. Use of hormone therapy and isoflavones and mammographic density in Spain.. Menopause. 2016;23 (5):556-64. doi: 10.1097/GME.0000000000000569. PubMed PMID:26731688 .

Search PubMed
  1. Benito L, Lluch MT, Falcó AM, García M, Puig M. Identifying Nursing Interventions in a Cancer Screening Program Using Nursing Interventions Classification Taxonomy.. Int J Nurs Knowl. 2017;28 (2):70-75. doi: 10.1111/2047-3095.12115. PubMed PMID:26411994 .

  2. Domènech X, Garcia M, Benito L, Binefa G, Vidal C, Milà N, Moreno V. [Interval cancers and episode sensitivity in population-based screening programmes for colorectal cancer: a systematic review].. Gac Sanit. ;29 (6):464-71. doi: 10.1016/j.gaceta.2015.07.002. PubMed PMID:26341155 .

  3. Castelló A, Prieto L, Ederra M, Salas-Trejo D, Vidal C, Sánchez-Contador C, Santamariña C, Pedraz C, Moreo P, Aragonés N, Pérez-Gómez B, Lope V, Vioque J, Pollán M, DDM-Spain research group. Association between the Adherence to the International Guidelines for Cancer Prevention and Mammographic Density.. PLoS One. 2015;10 (7):e0132684. doi: 10.1371/journal.pone.0132684. PubMed PMID:26208331 PubMed Central PMC4514863.

  4. Benito-Aracil L, Binefa-Rodriguez G, Milà-Diaz N, Lluch-Canut MT, Puig-Llobet M, Garcia-Martinez M. [Impact of an informative intervention on the colorectal cancer screening program in primary care professionals].. Enferm Clin. ;25 (5):223-31. doi: 10.1016/j.enfcli.2015.05.006. PubMed PMID:26165782 .

  5. Rodríguez-Alonso L, Rodríguez-Moranta F, Ruiz-Cerulla A, Lobatón T, Arajol C, Binefa G, Moreno V, Guardiola J. An urgent referral strategy for symptomatic patients with suspected colorectal cancer based on a quantitative immunochemical faecal occult blood test.. Dig Liver Dis. 2015;47 (9):797-804. doi: 10.1016/j.dld.2015.05.004. PubMed PMID:26055489 .

  6. Klabunde C, Blom J, Bulliard JL, Garcia M, Hagoel L, Mai V, Patnick J, Rozjabek H, Senore C, Törnberg S. Participation rates for organized colorectal cancer screening programmes: an international comparison.. J Med Screen. 2015;22 (3):119-26. doi: 10.1177/0969141315584694. PubMed PMID:25967088 .

  7. Garcia M, Domènech X, Vidal C, Torné E, Milà N, Binefa G, Benito L, Moreno V. Interval cancers in a population-based screening program for colorectal cancer in catalonia, Spain.. Gastroenterol Res Pract. 2015;2015 :672410. doi: 10.1155/2015/672410. PubMed PMID:25802515 PubMed Central PMC4354714.

  8. Peiró-Pérez R, Salas D, Vallés G, Abad-Fernandez MS, Vidal C, Sanchez-Contador Escudero C, Ascunce-Elizaga N, Zubizarreta R, Pedraz C, Pérez-Gómez B, Navarrete-Muñoz EM, Vioque J, Pollán M, DDM-Spain. Walking, biking or sport: how Spanish women attending breast cancer screening meet physical activity recommendations?. Eur J Public Health. 2015;25 (5):857-63. doi: 10.1093/eurpub/cku248. PubMed PMID:25767095 .

  9. Castells A, Andreu M, Binefa G, Fité A, Font R, Espinàs JA. Postpolypectomy surveillance in patients with adenomas and serrated lesions: a proposal for risk stratification in the context of organized colorectal cancer-screening programs.. Endoscopy. 2015;47 (1):86-7. doi: 10.1055/s-0034-1378100. PubMed PMID:25532113 .

  10. Castells X, Domingo L, Corominas JM, Torá-Rocamora I, Quintana MJ, Baré M, Vidal C, Natal C, Sánchez M, Saladié F, Ferrer J, Vernet M, Servitja S, Rodríguez-Arana A, Roman M, Espinàs JA, Sala M. Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program.. Breast Cancer Res Treat. 2015;149 (1):237-44. doi: 10.1007/s10549-014-3208-z. PubMed PMID:25503778 PubMed Central PMC4298666.

  11. Garcia M, Milà N, Binefa G, Benito L, Gonzalo N, Moreno V. Fecal hemoglobin concentration as a measure of risk to tailor colorectal cancer screening: are we there yet?. Eur J Cancer Prev. 2015;24 (4):321-7. doi: 10.1097/CEJ.0000000000000090. PubMed PMID:25370684 .

  12. Fernandez-Navarro P, González-Neira A, Pita G, Díaz-Uriarte R, Tais Moreno L, Ederra M, Pedraz-Pingarrón C, Sánchez-Contador C, Vázquez-Carrete JA, Moreo P, Vidal C, Salas-Trejo D, Stone J, Southey MC, Hopper JL, Pérez-Gómez B, Benitez J, Pollan M. Genome wide association study identifies a novel putative mammographic density locus at 1q12-q21.. Int J Cancer. 2015;136 (10):2427-36. doi: 10.1002/ijc.29299. PubMed PMID:25353672 .

Search PubMed